Effects of Instillation of Eyedrops Containing Disulfiram and Hydroxypropyl-β-Cyclodextrin Inclusion Complex on Endotoxin-Induced Uveitis in Rats

被引:21
|
作者
Kanai, Kazutaka [1 ]
Ito, Yoshimasa [2 ]
Nagai, Noriaki [2 ]
Itoh, Naoyuki [1 ]
Hori, Yasutomo [1 ]
Chikazawa, Seishirou [1 ]
Hoshi, Fumio [1 ]
Higuchi, Seiichi [1 ]
机构
[1] Kitasato Univ, Sch Vet Med, Dept Small Anim Internal Med, Towada, Aomori 0348628, Japan
[2] Kinki Univ, Sch Pharm, Dept Adv Design Pharmaceut, Higashiosaka, Osaka 577, Japan
关键词
Anti-inflammatory effects; Diethyldithiocarbamate; Disulfiram; Endotoxin-induced uveitis; Eyedrops; TUMOR-NECROSIS-FACTOR; SELENITE-TREATED RATS; NITRIC-OXIDE SYNTHASE; DRUG-DELIVERY SYSTEM; LEWIS RATS; PYRROLIDINE DITHIOCARBAMATE; EYE DROPS; INFLAMMATION; DIETHYLDITHIOCARBAMATE; INHIBITION;
D O I
10.3109/02713683.2011.622853
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To investigate the anti-inflammatory effects of the instillation of disulfirum (DSF) eyedrops that enhance solubility using 2-hydroxypropyl-beta-cyclodextrin (HP beta CD) and hydroxypropylmethylcellulose (HPMC) on endotoxin-induced uveitis (EIU) in rats and mechanisms related to ocular inflammation. Methods: EIU was induced in male Lewis rats by subcutaneous injection of 200 mu g lipopolysaccharide (LPS). DSF (0.125%, 0.25% and 0.5%) or commercially available 0.05% dexamethasone (Dexa) was topically applied to both eyes of rats 1 hour before, immediately after, and 1 and 2 hours after injection of LPS. The aqueous humor (AqH) was collected 24 hours after LPS injection, and the number of infiltrating cells, protein concentration, and levels of tumor necrosis factor-alpha (TNF-alpha), nitric oxide (NO) and prostaglandin E2 (PGE2) were determined. Immunohistochemical analysis of the iris ciliary body (ICB) cells was performed to determine the expression of activated nuclear factor kappa B (NF-kappa B), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Results: The topical administration with DSF suppressed, in a dose-dependent manner, the number of inflammatory cells, the protein concentration, and the levels of NO, TNF-alpha and PGE2 in the AqH and improved the histologic status of the ocular tissue. The anti-inflammatory potency of 0.5% DSF treatment was as strong as that of 0.05% Dexa. Topical DSF treatment also suppressed the activated NF-kappa B 3 hours after LPS injection, and iNOS and COX-2 expression in the ICB 24 hours after LPS injection. Conclusions: The present results demonstrate that the topical instillation of DSF eyedrops suppresses the inflammation in EIU, suggesting a possible novel approach for the treatment of ocular inflammation.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 45 条
  • [21] Apoptosis induced by the inclusion complex of dihydromyricetin with hydroxypropyl-β-cyclodextrin in Human Hep G2 cells
    Yang, Jiguo
    Liu, Benguo
    Liu, Feng
    Zhang, Yuan
    JOURNAL OF MEDICINAL PLANTS RESEARCH, 2011, 5 (01): : 114 - 118
  • [22] The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats
    Impellizzeri, Daniela
    Ahmad, Akbar
    Bruschetta, Giuseppe
    Di Paola, Rosanna
    Crupi, Rosalia
    Paterniti, Irene
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 761 : 28 - 35
  • [23] Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats
    Mangano, K.
    Sardesai, N. Y.
    Quattrocchi, C.
    Mazzon, E.
    Cuzzocrea, S.
    Bendtzen, K.
    Meroni, P. L.
    Kim, J. J.
    Nicoletti, F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (05) : 722 - 730
  • [24] The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats
    Lemaitre, C
    Thillaye-Goldenberg, B
    Naud, MC
    de Kozak, Y
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (09) : 2022 - 2030
  • [25] Inhibitory Effects of Proteasome Inhibitor Bortezomib on Endotoxin-Induced Uveitis in Lewis Rats
    Yang, C. -H.
    Liu, Y. -C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [26] Evaluation of XG-102 effects in the treatment of endotoxin-induced uveitis in rats
    El-Zaoui, Ikram
    Touchard, Elodie
    Polak, Marianne Berdugo
    Abadie, Claire
    Deloche, Catherine
    Combette, Jean-Marc
    Behar-Cohen, Francine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [27] Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects
    Lima, Bruno dos Santos
    Campos, Caio de Alcantara
    Ramos da Silva Santos, Anna Clara
    Nunes Santos, Victoria Caroline
    Gomes Trindade, Gabriela das Gracas
    Shanmugam, Saravanan
    Menezes Pereira, Erik Willyame
    Marreto, Ricardo Neves
    Duarte, Marcelo Cavalcante
    Guedes da Silva Almeida, Jackson Roberto
    Siqueira Quintans, Jullyana de Souza
    Quintans, Lucindo Jose, Jr.
    de Souza Araujo, Adriano Antunes
    FOOD AND CHEMICAL TOXICOLOGY, 2019, 126 : 15 - 24
  • [28] The hydroxypropyl-β-cyclodextrin-minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia
    Maqoud, Fatima
    Zizzo, Nicola
    Mele, Antonietta
    Denora, Nunzio
    Passantino, Giuseppe
    Scala, Rosa
    Cutrignelli, Annalisa
    Tinelli, Antonella
    Laquintana, Valentino
    la Forgia, Flavia
    Fontana, Sergio
    Franco, Massimo
    Lopedota, Angela Assunta
    Tricarico, Domenico
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (03):
  • [29] Therapeutic anti-inflammatory effects of luteolin on endotoxin-induced uveitis in Lewis rats
    Kanai, Kazutaka
    Nagata, Sho
    Hatta, Takuya
    Sugiura, Yuichi
    Sato, Kazuaki
    Yamashita, Yohei
    Kimura, Yuya
    Itoh, Naoyuki
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2016, 78 (08): : 1381 - 1384
  • [30] Curve-fitting FTIR studies of loratadine/hydroxypropyl-β-cyclodextrin inclusion complex induced by co-grinding process
    Lin, Shan-Yang
    Hsu, Cheng-Hung
    Sheu, Ming-Thau
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 53 (03) : 799 - 803